Avior Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.7M Buy
6,424
+354
+6% +$362K 0.2% 102
2026
Q1
$5.58M Buy
6,070
+615
+11% +$623K 0.16% 124
2025
Q4
$5.86M Sell
5,455
-733
-12% -$701K 0.18% 101
2025
Q3
$4.72M Buy
6,188
+750
+14% +$558K 0.15% 111
2025
Q2
$4.24M Hold
5,438
0.15% 115
2025
Q1
$4.49M Buy
5,438
+185
+4% +$154K 0.17% 99
2024
Q4
$4.06M Buy
5,253
+414
+9% +$343K 0.15% 110
2024
Q3
$4.29M Sell
4,839
-64
-1% -$57.5K 0.17% 101
2024
Q2
$4.44M Sell
4,903
-1,612
-25% -$1.29M 0.19% 92
2024
Q1
$5.07M Buy
6,515
+1,580
+32% +$1.12M 0.24% 81
2023
Q4
$2.88M Buy
4,935
+72
+1% +$42K 0.17% 108
2023
Q3
$2.61M Sell
4,863
-307
-6% -$158K 0.18% 104
2023
Q2
$2.42M Sell
5,170
-358
-6% -$150K 0.16% 114
2023
Q1
$1.9M Buy
5,528
+457
+9% +$154K 0.13% 122
2022
Q4
$1.86M Sell
5,071
-49
-1% -$17.4K 0.14% 122
2022
Q3
$1.66M Sell
5,120
-99
-2% -$31.4K 0.14% 120
2022
Q2
$1.69M Sell
5,219
-488
-9% -$146K 0.17% 107
2022
Q1
$1.63M Sell
5,707
-1
-0% -$257 0.14% 119
2021
Q4
$1.57M Sell
5,708
-1,363
-19% -$346K 0.13% 128
2021
Q3
$1.63M Buy
7,071
+2,497
+55% +$616K 0.13% 127
2021
Q2
$1.05M Sell
4,574
-32
-0.7% -$6.43K 0.11% 171
2021
Q1
$859K Buy
4,606
+603
+15% +$118K 0.09% 198
2020
Q4
$675K Sell
4,003
-100
-2% -$14.9K 0.08% 203
2020
Q3
$606K Sell
4,103
-641
-14% -$99.2K 0.09% 202
2020
Q2
$778K Sell
4,744
-129
-3% -$19.8K 0.12% 159
2020
Q1
$675K Sell
4,873
-469
-9% -$64.4K 0.13% 158
2019
Q4
$701K Hold
5,342
0.11% 184
2019
Q3
$596K Buy
5,342
+59
+1% +$6.57K 0.1% 184
2019
Q2
$585K Buy
5,283
+368
+7% +$43.3K 0.1% 183
2019
Q1
$637K Sell
4,915
-683
-12% -$83.1K 0.14% 161
2018
Q4
$647K Buy
5,598
+225
+4% +$25.1K 0.16% 134
2018
Q3
$577K Sell
5,373
-780
-13% -$78K 0.12% 157
2018
Q2
$525K Sell
6,153
-43
-0.7% -$3.53K 0.12% 163
2018
Q1
$479K Sell
6,196
-457
-7% -$36.8K 0.11% 171
2017
Q4
$562K Buy
6,653
+4,335
+187% +$369K 0.13% 155
2017
Q3
$198K Buy
2,318
+100
+5% +$8.2K 0.07% 137
2017
Q2
$183K Hold
2,218
0.07% 120
2017
Q1
$187K Sell
2,218
-200
-8% -$16K 0.06% 150
2016
Q4
$178K Hold
2,418
0.07% 141
2016
Q3
$194K Hold
2,418
0.08% 136
2016
Q2
$190K Hold
2,418
0.08% 132
2016
Q1
$174K Buy
2,418
+325
+16% +$24.6K 0.08% 130
2015
Q4
$176K Hold
2,093
0.1% 120
2015
Q3
$175K Sell
2,093
-199
-9% -$16.8K 0.1% 111
2015
Q2
$191K Buy
2,292
+320
+16% +$24.4K 0.15% 65
2015
Q1
$143K Hold
1,972
0.11% 79
2014
Q4
$136K Hold
1,972
0.11% 78
2014
Q3
$128K Hold
1,972
0.11% 77
2014
Q2
$123K Sell
1,972
-984
-33% -$58.7K 0.1% 76
2014
Q1
$174K Sell
2,956
-968
-25% -$54K 0.15% 60
2013
Q4
$200K Buy
+3,924
New +$196K 0.19% 55

Other funds holding LLY

Avior Wealth Management's LLY Position: Q2 2026 in Review

Avior Wealth Management increased its Eli Lilly (LLY) stake by 5.8% in Q2 2026, buying an estimated $362K and bringing the position to 6,424 shares worth $7.7M. The position accounts for 0.2% of the portfolio, ranked #102.

Avior Wealth Management first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. 1,651 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Avior Wealth Management held 6,424 shares of Eli Lilly worth $7.7M as of Q2 2026.
  • Avior Wealth Management bought 354 Eli Lilly shares in Q2 2026, an estimated $362K.
  • Eli Lilly made up 0.2% of Avior Wealth Management's portfolio in Q2 2026, its #102 holding.
  • Avior Wealth Management first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
  • 1,651 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.